5Aguado M T. Future approaches to vaccine development: Single - dose vaccines using controlled - release dilivery syetem. Vaccine,1993, 11:596.
6Stevens HNE, Wilson CG, Welling PG, et al. Evaluation of Pulsincap to provide regionl delivery of dofetilide to the human GI tract. Int J Pharm, 2002, 236(1) :27.
7Lemmer B. Implications of chronopharmacokinetics for drug delivery: antiasthmatics, H2 - blochers and cardiovascular active drugs. Adv Drug Deliv Rev, 1991,6(1) :83.
6Lemmer B. Circadian rhythms and drug delivery[J].J Controlled Release, 19 91,16 ( 1- 2 ) : 63-74.
7Junginger HE. Oral Applications of Pulsatile Delivery[A]. Pulsatile Drug Delivery---Current Application and Futures Trends [C ]. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1993. 113-134.
8Lemmer B. Implications of chronopharmacokinetics for drug delivery. antiasthmatics, H2-blockers and cardiovascular active drug [J]. Adv Drug Delivery Rev, 1991,6(1):83-100.
9Conte U,Colombo P, Manna A La,et al. A new ibuprofen pulsed release oral dosage form [J]. Drug Delivery Ind Pharm, 1989,15 (1): 14-16.
10Flaherty JT. Nitrate tolerance : A review of evidence[J]. Drugs, 1989,37:523-550.
